EA201291105A1 - Пероральная вакцина, содержащая антиген и агонист toll-подобного рецептора - Google Patents
Пероральная вакцина, содержащая антиген и агонист toll-подобного рецептораInfo
- Publication number
- EA201291105A1 EA201291105A1 EA201291105A EA201291105A EA201291105A1 EA 201291105 A1 EA201291105 A1 EA 201291105A1 EA 201291105 A EA201291105 A EA 201291105A EA 201291105 A EA201291105 A EA 201291105A EA 201291105 A1 EA201291105 A1 EA 201291105A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- toll
- agonist
- receptor
- vaccine containing
- containing antigen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
В изобретении предлагается иммуногенная композиция, содержащая один или более антигенов и агонист Toll-подобного рецептора (TLR) в перорально (например, сублингвально) вводимой композиции.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1009273.2A GB201009273D0 (en) | 2010-06-03 | 2010-06-03 | Novel vaccine |
PCT/EP2011/059167 WO2011151431A1 (en) | 2010-06-03 | 2011-06-02 | Oral vaccine comprising an antigen and a toll-like receptor agonist |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201291105A1 true EA201291105A1 (ru) | 2013-05-30 |
Family
ID=42471081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201291105A EA201291105A1 (ru) | 2010-06-03 | 2011-06-02 | Пероральная вакцина, содержащая антиген и агонист toll-подобного рецептора |
Country Status (15)
Country | Link |
---|---|
US (1) | US20130089570A1 (ru) |
EP (1) | EP2575871A1 (ru) |
JP (1) | JP2013527218A (ru) |
KR (1) | KR20130082139A (ru) |
CN (1) | CN102905726A (ru) |
AU (1) | AU2011260215B2 (ru) |
BR (1) | BR112012030552A2 (ru) |
CA (1) | CA2801266A1 (ru) |
EA (1) | EA201291105A1 (ru) |
GB (1) | GB201009273D0 (ru) |
IL (1) | IL223151A0 (ru) |
MX (1) | MX2012014083A (ru) |
SG (1) | SG185729A1 (ru) |
WO (1) | WO2011151431A1 (ru) |
ZA (1) | ZA201208915B (ru) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8067237B2 (en) | 2005-12-13 | 2011-11-29 | President And Fellows Of Harvard College | Scaffolds for cell transplantation |
WO2009002401A2 (en) | 2007-06-21 | 2008-12-31 | President And Fellows Of Harvard College | Scaffolds for cell collection or elimination |
JP5690143B2 (ja) | 2008-02-13 | 2015-03-25 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 持続的細胞プログラミング装置 |
US9370558B2 (en) | 2008-02-13 | 2016-06-21 | President And Fellows Of Harvard College | Controlled delivery of TLR agonists in structural polymeric devices |
WO2009146456A1 (en) | 2008-05-30 | 2009-12-03 | President And Fellows Of Harvard College | Controlled release of growth factors and signaling molecules for promoting angiogenesis |
US9297005B2 (en) | 2009-04-13 | 2016-03-29 | President And Fellows Of Harvard College | Harnessing cell dynamics to engineer materials |
AU2010278702C1 (en) | 2009-07-31 | 2016-07-14 | Forsyth Dental Infirmary For Children | Programming of cells for tolerogenic therapies |
EP2542230A4 (en) | 2010-03-05 | 2013-08-28 | Harvard College | ENHANCEMENT OF SKELETAL MUSCLE STRAIN CELL GRAFT WITH DUAL DELIVERY OF VEGF AND IGF-1 |
EP2585053A4 (en) | 2010-06-25 | 2014-02-26 | Harvard College | COMMON RELEASE OF STIMULATING AND HEMMING FACTORS FOR THE PRODUCTION OF TEMPORARY STABILIZED AND SPATULARLY LIMITED ZONES |
CN107648668B (zh) | 2010-10-06 | 2021-06-18 | 哈佛学院董事会 | 用于基于材料的细胞疗法的可注射的成孔水凝胶 |
KR101751964B1 (ko) | 2010-10-08 | 2017-06-28 | 알.피.쉐러 테크놀러지즈 엘엘씨 | 전분을 이용한 경구 백신 급속 용해성 투여 형태 |
US9603894B2 (en) | 2010-11-08 | 2017-03-28 | President And Fellows Of Harvard College | Materials presenting notch signaling molecules to control cell behavior |
EP2701753B1 (en) | 2011-04-27 | 2018-12-26 | President and Fellows of Harvard College | Cell-friendly inverse opal hydrogels for cell encapsulation, drug and protein delivery, and functional nanoparticle encapsulation |
US9675561B2 (en) | 2011-04-28 | 2017-06-13 | President And Fellows Of Harvard College | Injectable cryogel vaccine devices and methods of use thereof |
EP2701745B1 (en) | 2011-04-28 | 2018-07-11 | President and Fellows of Harvard College | Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration |
US9486512B2 (en) | 2011-06-03 | 2016-11-08 | President And Fellows Of Harvard College | In situ antigen-generating cancer vaccine |
GB201119999D0 (en) * | 2011-11-20 | 2012-01-04 | Glaxosmithkline Biolog Sa | Vaccine |
CN109125718A (zh) * | 2012-01-13 | 2019-01-04 | 哈佛学院董事会 | 在结构聚合装置中tlr激动剂的控制传递 |
EP2804613A4 (en) | 2012-01-16 | 2015-12-09 | Elizabeth Mckenna | COMPOSITIONS AND METHODS FOR TREATING DISEASES AND HEPATIC DISORDERS |
JP5650780B2 (ja) * | 2012-04-04 | 2015-01-07 | 日東電工株式会社 | ワクチン組成物 |
WO2013158673A1 (en) | 2012-04-16 | 2013-10-24 | President And Fellows Of Harvard College | Mesoporous silica compositions for modulating immune responses |
WO2014047588A1 (en) | 2012-09-21 | 2014-03-27 | Elizabeth Mckenna | Naturally occurring cpg oligonucleotide compositions and therapeutic applications thereof |
KR20140100422A (ko) * | 2013-02-05 | 2014-08-14 | 닛토덴코 가부시키가이샤 | 백신 조성물 |
CN103961702B (zh) * | 2013-02-05 | 2019-04-09 | 日东电工株式会社 | 粘膜给予用wt1肽癌症疫苗组合物 |
JP2014169275A (ja) * | 2013-02-05 | 2014-09-18 | Nitto Denko Corp | 粘膜投与用ワクチン組成物 |
US20150086592A1 (en) * | 2013-09-25 | 2015-03-26 | Sequoia Sciences, Inc | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
KR20160058773A (ko) | 2013-10-03 | 2016-05-25 | 닛토덴코 가부시키가이샤 | 점막 백신 조성물 |
RU2016109150A (ru) * | 2013-10-03 | 2017-11-10 | Нитто Денко Корпорейшн | Мукозальная вакцинная композиция |
CN107073090A (zh) | 2014-04-30 | 2017-08-18 | 哈佛学院董事会 | 结合的疫苗装置和杀死癌细胞的方法 |
EP2950095B1 (en) * | 2014-05-28 | 2018-08-29 | Technische Universität Dresden | Cell-based assay and screening methods for modulators of p75NTR signaling |
KR101586468B1 (ko) * | 2014-12-30 | 2016-01-18 | 성균관대학교산학협력단 | 아주번트 조성물, 이의 제조 방법, 및 이를 포함하는 백신 조성물 |
KR101577955B1 (ko) * | 2014-12-31 | 2015-12-16 | 성균관대학교산학협력단 | 아주번트 조성물, 이의 제조 방법, 및 이를 포함하는 백신 조성물 |
WO2016123573A1 (en) | 2015-01-30 | 2016-08-04 | President And Fellows Of Harvard College | Peritumoral and intratumoral materials for cancer therapy |
CN114099793A (zh) | 2015-04-10 | 2022-03-01 | 哈佛学院院长等 | 免疫细胞捕获装置及其制备和使用方法 |
WO2016168696A1 (en) * | 2015-04-15 | 2016-10-20 | Ohio State Innovation Foundation | Methods to improve induction of iga antibodies by vaccines |
KR101595949B1 (ko) * | 2015-05-27 | 2016-02-19 | 성균관대학교산학협력단 | 아주번트 조성물 및 백신 조성물의 제조 방법 |
WO2017136837A1 (en) | 2016-02-06 | 2017-08-10 | President And Fellows Of Harvard College | Recapitulating the hematopoietic niche to reconstitute immunity |
CN115537372A (zh) | 2016-07-13 | 2022-12-30 | 哈佛学院院长等 | 抗原呈递细胞模拟支架及其制备和使用方法 |
US10508115B2 (en) * | 2017-08-16 | 2019-12-17 | Bristol-Myers Squibb Company | Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor |
CN108498362A (zh) * | 2018-04-17 | 2018-09-07 | 睿欧生物科技(上海)有限公司 | 预防及治疗口腔溃疡的Toll样受体激动剂漱口水 |
US20200215185A1 (en) * | 2019-01-09 | 2020-07-09 | Emv Enhance (Hk) Limited | Compositions and methods for enhancing immune response to vaccination and improving vaccine production |
CN112778372A (zh) * | 2019-11-11 | 2021-05-11 | 苏州泽璟生物制药股份有限公司 | 咪唑并喹啉取代磷酸酯类激动剂及其制备方法和应用 |
CN114377122B (zh) * | 2022-01-18 | 2023-04-07 | 四川大学 | 一种基于四面体框架核酸的复合佐剂、mRNA疫苗及其制备方法和用途 |
WO2024004159A1 (ja) * | 2022-06-30 | 2024-01-04 | Eps創薬株式会社 | 舌下投与用ワクチン組成物 |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988009797A1 (en) | 1987-06-05 | 1988-12-15 | The United States Of America, As Represented By Th | Autocrine motility factors in cancer diagnosis and management |
US5278302A (en) | 1988-05-26 | 1994-01-11 | University Patents, Inc. | Polynucleotide phosphorodithioates |
US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
EP0468520A3 (en) | 1990-07-27 | 1992-07-01 | Mitsui Toatsu Chemicals, Inc. | Immunostimulatory remedies containing palindromic dna sequences |
JPH05339169A (ja) * | 1992-03-03 | 1993-12-21 | Dai Ichi Seiyaku Co Ltd | 経口ワクチン |
KR950700083A (ko) * | 1992-03-03 | 1995-01-16 | 스즈키 다다시 | 경구용 백신(oral vaccine) |
CA2158040A1 (en) * | 1993-03-11 | 1994-09-15 | Jacqueline D. Duncan | Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces |
AU685443B2 (en) | 1993-03-23 | 1998-01-22 | Smithkline Beecham Biologicals (Sa) | Vaccine compositions containing 3-O deacylated monophosphoryl lipid A |
RU2154068C2 (ru) | 1993-11-17 | 2000-08-10 | Лаборатуар Ом С.А. | Глюкозаминовые дисахариды, способ их получения, фармацевтическая композиция |
WO1995026204A1 (en) | 1994-03-25 | 1995-10-05 | Isis Pharmaceuticals, Inc. | Immune stimulation by phosphorothioate oligonucleotide analogs |
US5666153A (en) | 1995-10-03 | 1997-09-09 | Virtual Shopping, Inc. | Retractable teleconferencing apparatus |
US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
US6764840B2 (en) | 1997-05-08 | 2004-07-20 | Corixa Corporation | Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
US6303347B1 (en) | 1997-05-08 | 2001-10-16 | Corixa Corporation | Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
US20020197321A1 (en) * | 1997-10-27 | 2002-12-26 | Harry Seager | Solid dispersing vaccine composition for oral delivery |
GB9722682D0 (en) | 1997-10-27 | 1997-12-24 | Scherer Ltd R P | Pharmaceutical products |
WO1999064301A1 (fr) | 1998-06-08 | 1999-12-16 | Sca Emballage France | Emballage a remise a plat rapide |
CZ302062B6 (cs) | 1998-06-30 | 2010-09-22 | Om Pharma | Derivát acyldipeptidu, zpusob jeho prípravy, meziprodukty pro jeho prípravu a farmaceutický prostredek, který ho obsahuje |
AU1581400A (en) | 1999-12-22 | 2001-07-03 | Om Pharma | Acyl pseudopeptides bearing a functionalised auxiliary spacer |
GB0000891D0 (en) * | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
EP1311522B1 (en) * | 2000-08-04 | 2006-03-22 | Corixa Corporation | New immunoeffector compounds |
GB0020089D0 (en) * | 2000-08-15 | 2000-10-04 | Smithkline Beecham Biolog | Vaccine Composition |
ES2314042T3 (es) | 2001-04-17 | 2009-03-16 | Dainippon Sumitomo Pharma Co., Ltd. | Derivados nuevos de adenina. |
ATE416771T1 (de) | 2001-11-16 | 2008-12-15 | 3M Innovative Properties Co | N-ä4-(4-amino-2-ethyl-1h-imidazoä4,5-cüchinolin 1-yl)butylümethanesulfonamide, diese enthaltende pharmazeutische zusammensetzung und deren verwendung |
US7030094B2 (en) * | 2002-02-04 | 2006-04-18 | Corixa Corporation | Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21 |
US7288640B2 (en) | 2002-07-08 | 2007-10-30 | Corixa Corporation | Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor |
US7960522B2 (en) * | 2003-01-06 | 2011-06-14 | Corixa Corporation | Certain aminoalkyl glucosaminide phosphate compounds and their use |
ES2639812T3 (es) * | 2003-01-06 | 2017-10-30 | Corixa Corporation | Ciertos compuestos de fosfato de aminoalquil glucosaminida y sus usos |
US7375180B2 (en) | 2003-02-13 | 2008-05-20 | 3M Innovative Properties Company | Methods and compositions related to IRM compounds and Toll-like receptor 8 |
WO2006069262A2 (en) * | 2004-12-21 | 2006-06-29 | Vaxinnate Corporation | Compositions of influenza viral proteins and methods of use thereof |
US20080233105A1 (en) * | 2005-09-13 | 2008-09-25 | Green William R | Compositions and methods for preventing or treating a viral infection |
EP1951299B1 (en) * | 2005-11-04 | 2012-01-04 | Novartis Vaccines and Diagnostics S.r.l. | Influenza vaccines including combinations of particulate adjuvants and immunopotentiators |
US20090047353A1 (en) * | 2005-11-04 | 2009-02-19 | Novartis Vaccines And Diagnostics Srl | Changing th1/th2 balance in split influenza vaccines with adjuvants |
ITMI20061117A1 (it) * | 2006-06-09 | 2007-12-10 | Michele Bonanomi | Una composizione farmaceutica per la somministrazione sublinguale di vaccini metodo per la sua preparazione e sui usi |
CA2601358A1 (en) * | 2006-09-08 | 2008-03-08 | Duotol Ab | Method for inducing mucosal humoral and cell-mediated immune responses by sublingual administration of antigens |
US20080112974A1 (en) * | 2006-09-08 | 2008-05-15 | Duotol Ab | Method for inducing mucosal humoral and cell-mediated immune responses by sublingual administration of antigens |
PE20090146A1 (es) * | 2007-04-20 | 2009-03-23 | Glaxosmithkline Biolog Sa | Composicion inmunogenica contra el virus influenza |
EP2058002A1 (en) * | 2007-10-31 | 2009-05-13 | Bestewil Holding B.V. | Reconstituted respiratory syncytial virus membranes and use as respiratory syncytial virus vaccine |
JP5775451B2 (ja) * | 2008-06-19 | 2015-09-09 | バリエーション バイオテクノロジーズ インコーポレイティド | インフルエンザを処置するための組成物および方法 |
EP2300609B1 (en) | 2008-06-25 | 2013-11-20 | INSERM - Institut National de la Santé et de la Recherche Médicale | Novel immunoadjuvant flagellin-based compounds and use thereof |
EP2303236A4 (en) * | 2008-07-01 | 2012-09-26 | Univ Emory | SYNERGISTIC INDUCTION OF HUMOR AND CELLULAR IMMUNITY BY COMBINATORY ACTIVATION OF TOLL-LIKE RECEPTORS |
AU2009283557B2 (en) * | 2008-08-18 | 2013-01-17 | Kitasato Daiichi Sankyo Vaccine Co., Ltd. | Avian influenza virus antigen, and booster immunization method for avian influenza vaccine in combination with mucosal adjuvant which is effective through oral administration |
MX2011004249A (es) * | 2008-10-24 | 2011-07-20 | Glaxosmithkline Biolog Sa | Derivados de imidazoquinolina lipidados. |
CN101524537B (zh) * | 2009-03-26 | 2012-11-28 | 成都康华生物制品有限公司 | 流感口服含片疫苗、流感口服缓释疫苗以及二者制备方法 |
WO2010111586A2 (en) * | 2009-03-27 | 2010-09-30 | Arizona Board Of Regents Acting For And On Behalf Of Arizona State University | Mucosal immunization |
EP2308506A1 (en) * | 2009-10-02 | 2011-04-13 | Mucosis B.V. | Adjuvanted intranasal vaccine formulations |
WO2011057267A1 (en) * | 2009-11-09 | 2011-05-12 | National Jewish Health | Vaccine composition |
-
2010
- 2010-06-03 GB GBGB1009273.2A patent/GB201009273D0/en not_active Ceased
-
2011
- 2011-02-06 US US13/701,237 patent/US20130089570A1/en not_active Abandoned
- 2011-06-02 EA EA201291105A patent/EA201291105A1/ru unknown
- 2011-06-02 JP JP2013512932A patent/JP2013527218A/ja active Pending
- 2011-06-02 KR KR1020137000048A patent/KR20130082139A/ko not_active Application Discontinuation
- 2011-06-02 CN CN2011800273836A patent/CN102905726A/zh active Pending
- 2011-06-02 SG SG2012086294A patent/SG185729A1/en unknown
- 2011-06-02 BR BR112012030552A patent/BR112012030552A2/pt not_active IP Right Cessation
- 2011-06-02 MX MX2012014083A patent/MX2012014083A/es not_active Application Discontinuation
- 2011-06-02 CA CA2801266A patent/CA2801266A1/en not_active Abandoned
- 2011-06-02 AU AU2011260215A patent/AU2011260215B2/en not_active Ceased
- 2011-06-02 WO PCT/EP2011/059167 patent/WO2011151431A1/en active Application Filing
- 2011-06-02 EP EP11724181.0A patent/EP2575871A1/en not_active Withdrawn
-
2012
- 2012-11-20 IL IL223151A patent/IL223151A0/en unknown
- 2012-11-26 ZA ZA2012/08915A patent/ZA201208915B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2011260215A1 (en) | 2013-01-17 |
IL223151A0 (en) | 2013-02-03 |
CA2801266A1 (en) | 2011-12-08 |
WO2011151431A1 (en) | 2011-12-08 |
CN102905726A (zh) | 2013-01-30 |
GB201009273D0 (en) | 2010-07-21 |
AU2011260215B2 (en) | 2014-06-12 |
SG185729A1 (en) | 2012-12-28 |
KR20130082139A (ko) | 2013-07-18 |
EP2575871A1 (en) | 2013-04-10 |
JP2013527218A (ja) | 2013-06-27 |
ZA201208915B (en) | 2014-04-30 |
MX2012014083A (es) | 2013-01-29 |
BR112012030552A2 (pt) | 2016-08-16 |
US20130089570A1 (en) | 2013-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201291105A1 (ru) | Пероральная вакцина, содержащая антиген и агонист toll-подобного рецептора | |
CY1120328T1 (el) | Συνθεση εμβολιου περιεχουσα συνθετικο ανοσοενισχυτικο | |
CY1118492T1 (el) | Φαρμακοτεχνικες μορφες εμβολιου norovirus | |
CY1122786T1 (el) | Δοσολογικα σχηματα για ενωσεις κατηγοριας εχινοκανδινης | |
EA201100268A1 (ru) | Вакцина | |
CR20120310A (es) | Anticuerpos neutralizadores contra el receptor de prolactina y su uso terapéutico | |
CY1117331T1 (el) | Αντισωματα προσδεσης στην εξωκυτταρικη περιοχη 4 του ανθρωπινου csf1r και η χρηση αυτων | |
TR201802380T4 (tr) | Benzonaftiridin içeren aşılar. | |
MX2009001412A (es) | Vacunas de matriz de proteinas y metodos de hacer y administrar tales vacunas. | |
CY1115091T1 (el) | Διειδικες πρωτεϊνες προσδεσης αντιγονων | |
CL2013003145A1 (es) | Formulación farmacéutica que comprende mezcla de anticuerpo anti-alfa4beta7, un antioxidante o quelante y al menos un aminoácido libre. | |
CY1120430T1 (el) | Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων | |
CY1115932T1 (el) | Σκευασμα αντισωματος | |
EA200901340A1 (ru) | Вакцина | |
MX363307B (es) | Plataformas para suministro de antigenos. | |
BRPI1013780A2 (pt) | composições para imunização contra staphylococcus aureus. | |
WO2012027365A3 (en) | Targeted multi-epitope dosage forms for induction of an immune response to antigens | |
EA201170616A1 (ru) | Лекарственная форма ацетаминофен/трамадол с замедленным действием для перорального приема | |
CL2012003299A1 (es) | Vacuna que comprende uno o mas antigenos, uno o mas oligonucleotidos inmunoestimuladores aislados y colesterol; metodo para inducir una respuesta inmune antigeno específica en un sujeto que necesita de la misma. | |
CY1116904T1 (el) | Εμβολιο | |
EA201790239A1 (ru) | Молекула-носитель для антигенов | |
CR11307A (es) | Vacunas | |
CR20130632A (es) | El anticuerpo neutralizador del receptor de prolactina mat3 y su uso terapéutico | |
MX2016008640A (es) | Formulaciones de vacuna de vial unico. | |
BRPI0810865A2 (pt) | antígenos de tripanossoma, composições vacinais, e métodos relacionados |